CFLT vs EDIT
Confluent Inc (CFLT) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
Confluent Inc (CFLT) is a software - infrastructure company listed on US.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported CFLT revenue for 2024-12-31 was $963.6M. Net income was -$345.1M. Revenue was up 24.0% from 2023-12-31 to 2024-12-31. CFLT currently screens at market cap $11.13B.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
CFLT currently screens at market cap $11.13B. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the CFLT and EDIT stock pages for the full models.
Not investment advice.